<DOC>
	<DOCNO>NCT02579421</DOCNO>
	<brief_summary>The purpose study examine role progesterone ( naturally occur hormone find men woman ) reduce marijuana use . The investigator see progesterone effect impulsivity , withdrawal , mood stress marijuana cessation .</brief_summary>
	<brief_title>Hormones Reduction Co-users Marijuana Nicotine</brief_title>
	<detailed_description>This double-blind , randomize pilot clinical trial prescreen estimate 250 potential subject , consent evaluate approximately 100 potential subject , ultimately enroll 70 subject ensure 40 subject provide primary marijuana reduction outcome measure four week post quit date . Subjects stratify sex randomize one two treatment group ( n=20 per drug group , 50 % female ) : progesterone ( PRO ; 200mg 2x/day ) Placebo ( PBO ) . Telephone screen visit invitation ( 20 minute ) lead consent process in-person screen include medical-psychiatric evaluation inclusion/exclusion ( two visit , two hour ) , randomization medication start ( 7 day ) , stable medication ( 28 day ) medication reduction final evaluation ( 7 day ) .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<criteria>Males 1860 year old , females 1850 year old Stable physical mental health Selfreport Timeline FollowBack ( TLFB ) indicate current marijuana use ≥4 days/week ≥1 year Positive urine THC dipstick test ( &gt; 50ng/mL ; indicate marijuana use past 4872 hour ) Motivated change marijuana use ( &gt; 1 10point Likerttype scale ) Regular sporadic use nicotine cigarette ( &gt; 1 cigarette past 30 day ) Selfreport regular menstrual cycle &gt; 6 month ( female ) Willing use doublebarrier contraception sexually active surgically sterilize ( female ) Ability comply study procedure , ability provide inform consent . Current breastfeeding ( female ) , Current plan pregnancy within next three month ( female ) DSMIV diagnose psychotic disorder , bipolar disorder , ADHD , major depressive disorder within last 3 month Substance dependence within last 3 month exception nicotine marijuana dependence Unstable psychotropic medication ( &lt; 3 month ) Current use exogenous hormone , finasteroid ( propecia ) , efavirenz , red clover , ketoconazole drug CYP3A4 inhibitor Conditions contraindicate progesterone treatment ( include , limited , thrombophlebitis , deep vein thrombosis , pulmonary embolus , clot bleed disorder , heart disease , diabetes , history stroke , allergy peanut , hypersensitive progesterone liver dysfunction )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>